Condition
Hookworm
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03245398Phase 4CompletedPrimary
Efficacy and Safety of a Multi-dose Regimen of Mebendazole Against Hookworm in Children
NCT01658774Not ApplicableCompleted
Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
NCT01869127Not ApplicableCompletedPrimary
Study to Test Whether Shoes Protect Children Against Hookworm Infection on Pemba Island, Zanzibar
Showing all 3 trials